DexCom
DXCM
311 hedge funds and large institutions have $7.14B invested in DexCom in 2017 Q2 according to their latest regulatory filings, with 35 funds opening new positions, 146 increasing their positions, 87 reducing their positions, and 44 closing their positions.
68% more repeat investments, than reductions
Existing positions increased: 146 | Existing positions reduced: 87
26.12% more ownership
Funds ownership: 426.27% → 452.39% (+26%)
3% less funds holding
Funds holding: 321 → 311 (-10)
8% less capital invested
Capital invested by funds: $7.78B → $7.14B (-$640M)
20% less first-time investments, than exits
New positions opened: 35 | Existing positions closed: 44
97% less call options, than puts
Call options by funds: $17.1M | Put options by funds: $512M
100% less funds holding in top 10
Funds holding in top 10: 3 → 0 (-3)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Janus Henderson Group
London,
|
+$504M |
| 2 |
Winslow Capital Management
Minneapolis,
Minnesota
|
+$119M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
+$72.3M |
| 4 |
Bank of New York Mellon
New York
|
+$51.4M |
| 5 |
FAM
Fred Alger Management
New York
|
+$51.4M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$110M |
| 2 |
SPC
Slate Path Capital
New York
|
-$94.9M |
| 3 |
Artisan Partners
Milwaukee,
Wisconsin
|
-$75.8M |
| 4 |
CCI
Columbus Circle Investors
|
-$67.8M |
| 5 |
BM
Bridger Management
New York
|
-$32.6M |
DXCM Hedge Fund Activity: Q2 2017 in Review
311 of the 4,022 institutional investors tracked by Wall St. Rank reported a position in DexCom (DXCM) for Q2 2017, worth a combined $7.14B — down 8.2% from $7.78B a quarter earlier.
Sellers outnumbered buyers: 44 funds closed out of DXCM and 35 opened new positions — a net loss of 9 holders — while 87 trimmed existing stakes and 146 added.
The largest buyer was Janus Henderson Group, adding an estimated $504M. The largest seller was T. Rowe Price Associates, cutting an estimated $110M.
- 311 institutional investors held DexCom (DXCM) as of Q2 2017, down from 321 in Q1 2017.
- Funds reported $7.14B of DexCom stock for Q2 2017, down 8.2% quarter-over-quarter.
- 35 funds opened new DexCom positions in Q2 2017 and 44 closed out, a net change of -9 holders.
- The largest DexCom buyer in Q2 2017 was Janus Henderson Group, an estimated $504M added.
- The largest DexCom seller in Q2 2017 was T. Rowe Price Associates, an estimated $110M sold.
Based on aggregated 13F filings for Q2 2017.